Work

Abstract 13840: Safety Outcomes From a First-in-Human Study of a Novel Investigational Monoclonal Antibody, REGN5381, an Agonist to the Natriuretic Peptide Receptor 1

Year: 2023

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.148.suppl_1.13840

Authors: Aaron P Kithcart, Michael E Dunn, Jan de Hoon, Wouter Botermans, Satyajit Karnik, Michael E Burczynski, Wenjun Zheng, Andrew J Rankin, Gary Herman, Benjamin Olenchock

Institutions: Regeneron (United States), Universitair Ziekenhuis Leuven, KU Leuven

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4388420198

Cites:

Cited by: 1

Related to: 10